Predictive significance of tumor-associated miRNA-21 and -221 expression in patients with prostate cancer.

前列腺癌 小RNA 肿瘤进展 医学 癌症 免疫组织化学 克隆(Java方法) 前列腺 肿瘤科 阶段(地层学) 临床意义 病理 病态的 癌症研究 内科学 生物 基因 古生物学 生物化学
作者
Liliya Tryfonyuk,Т. Borikun,Taras Zadvornyi,O. Rossylna,Natalia Pavlukovich
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:40 (16_suppl): e17015-e17015 被引量:1
标识
DOI:10.1200/jco.2022.40.16_suppl.e17015
摘要

e17015 Background: It is thought that the occurrence and progression of tumors, such as prostate cancer (PCа), may be due to decreased levels of tumor-inhibiting microRNAs and/or overexpression of oncogenic microRNAs, but their specificity and role in tumor progression are contradictory. That is why the study of the possibility of using miRNAs as prognostic markers is especially relevant. Objective: to investigate the features of tumor -associated microRNAs-21 and -221 expression in PCa tissue with different risk of progression and to determine the relationship of their indicators with the molecular profile of tumors. Methods: The study was conducted on the clinical material of 60 patients with PCa stage II-III, who were treated in Rivne Regional Hospital and Rivne oncological center during 2018-2021 years. Determination of the risk of PCa progression was performed by D'Amico et al. (1998). Immunohistochemical study of Ki-67 expression (clone MIB -1) and androgen receptors (AR) (clone 441) were performed on paraffin sections of tumor tissue using the Ultra Vision LP Detection System (Thermo Scientific, USA). Determination of microRNA-21 and -221 levels were determined using real-time quantitative PCR. Statistical processing of the results was performed using GraphPad Prism 8. Results: It is determined that a characteristic feature of PCa with a low risk of progression by D'Amico et al . are low expression of oncogenic miRNA-21 and -221 in tumor tissue. In particular, in the PCa samples of high risk of progression (n = 30) the level of miRNA-21 was 3.2 times (p < 0.05), and miRNA-221 was 1.35 times (p < 0.05) higher compared to tumor tissue of patients with low progression (n = 30). The existence of a direct correlation between the expression of miRNA-21 and the proliferative activity of PCa (ρ = 0.63; p < 0.05) is shown. We found that the expression of miRNA-221 is associated with a high level of AR expression (ρ = 0.43; p < 0.05) . Conclusions: The obtained data indicate the relationship of tumor -associated microRNA-21 and -221 with the risk of tumor progression and such molecular biological characteristics of tumors as proliferative activity and receptor status, which indicates the prospects for their further study as additional markers for predicting of PCa course.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
盈盈完成签到 ,获得积分20
刚刚
乌龟gogogo完成签到 ,获得积分10
刚刚
刚刚
Luki完成签到,获得积分10
刚刚
深情未来完成签到,获得积分10
1秒前
ProfWang完成签到,获得积分10
1秒前
1秒前
xibei完成签到,获得积分10
2秒前
throbzhong完成签到,获得积分10
2秒前
科研通AI2S应助小巧的映易采纳,获得10
2秒前
牧童完成签到,获得积分10
2秒前
艾云欣发布了新的文献求助10
2秒前
zsy完成签到,获得积分10
2秒前
2秒前
动听千秋完成签到 ,获得积分10
3秒前
猫猫完成签到,获得积分10
3秒前
友好凡霜完成签到,获得积分20
3秒前
xin发布了新的文献求助10
3秒前
小巧元柏关注了科研通微信公众号
4秒前
wst1988完成签到,获得积分10
4秒前
5秒前
爱学习的翟浩琪完成签到,获得积分10
5秒前
123321完成签到,获得积分10
5秒前
liu完成签到,获得积分10
6秒前
科研通AI5应助小九九采纳,获得10
7秒前
7秒前
咄咄完成签到,获得积分10
7秒前
KalEl完成签到,获得积分10
7秒前
caizx完成签到,获得积分10
7秒前
完美世界应助萌大叔采纳,获得10
7秒前
xwy发布了新的文献求助10
7秒前
Phy完成签到,获得积分10
8秒前
NN发布了新的文献求助30
8秒前
科研通AI5应助看不懂采纳,获得10
8秒前
可可西里完成签到,获得积分10
8秒前
连垣完成签到,获得积分10
8秒前
跳跃的惮发布了新的文献求助10
9秒前
9秒前
齐桓公完成签到,获得积分10
9秒前
aigj完成签到 ,获得积分10
9秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
All the Birds of the World 4000
Production Logging: Theoretical and Interpretive Elements 3000
Musculoskeletal Pain - Market Insight, Epidemiology And Market Forecast - 2034 2000
Animal Physiology 2000
Am Rande der Geschichte : mein Leben in China / Ruth Weiss 1500
CENTRAL BOOKS: A BRIEF HISTORY 1939 TO 1999 by Dave Cope 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3746471
求助须知:如何正确求助?哪些是违规求助? 3289359
关于积分的说明 10064159
捐赠科研通 3005740
什么是DOI,文献DOI怎么找? 1650360
邀请新用户注册赠送积分活动 785858
科研通“疑难数据库(出版商)”最低求助积分说明 751296